Prestige Consumer Healthcare (PBH) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Prestige Consumer Healthcare (PBH) is Neutral.

The composite score behind that read is +0.18, weighing +0.46 of bullish evidence against -0.21 bearish.

Prestige Consumer Healthcare last closed at $48.23, +0.75% on the session.

Against the IVW growth benchmark the position is -0.05% over the forecast window.

The read is built from 15 underlying insights — 8 bullish and 7 bearish.

Agreement across those insights is 53%.

4 graded predictions for PBH so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Prestige Consumer Healthcare in the 69th percentile on valuation and the 58th percentile on return on equity, where 100 is best.

Prestige Consumer Healthcare is classified under Health Care / Pharmaceuticals, with a market capitalisation of $2.27B.

StockMap tracks Prestige Consumer Healthcare as the 38th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Prestige Consumer Healthcare ranks 19th of 151 in the group, against a group median of -0.08.